FDA Adverse Event Injury Summary report: N

ACTIVA

MDR report key: 3512893 · Received December 10, 2013

Report

Report Number
3007566237-2013-03978
Event Type
Injury
Date Received
December 10, 2013
Date of Event
October 3, 2013
Report Date
November 12, 2013
Manufacturer
MEDTRONIC MED REL MEDTRONIC PUERTO RICO
Product Code
MHY
PMA / PMN Number
H050003
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE ACTUAL EVENT DATES WERE NOT PROVIDED. THIS DATE IS BASED ON THE DATE OF PUBLICATION OF THE ARTICLE. IT WAS NOT POSSIBLE TO ASCERTAIN SPECIFIC DEVICE INFORMATION FROM THE ARTICLE OR TO MATCH THE EVENTS REPORTED WITH PREVIOUSLY REPORTED EVENTS. PRODUCT ID: NEU_UNKNOWN_LEAD, LOT# UNKNOWN, PRODUCT TYPE: LEAD. (B)(4).

Description of Event or Problem · 1

O'RAWE, J. A., FANG, H., RYNEARSON, S., ROBISON, R., KIRULUTA, E. S., HIGGINS, G., EILBECK, K., REESE, M. G., LYON, G. J. INTEGRATING PRECISION MEDICINE IN THE STUDY AND CLINICAL TREATMENT OF A SEVERELY MENTALLY ILL PERSON. PEERJ. 2013;1:E177. DOI 10.7717/PEERJ.177. SUMMARY: IN RECENT YEARS, THERE HAS BEEN AN EXPLOSION IN THE NUMBER OF TECHNICAL AND MEDICAL DIAGNOSTIC PLATFORMS BEING DEVELOPED. THIS HAS GREATLY IMPROVED OUR ABILITY TO MORE ACCURATELY, AND MORE COMPREHENSIVELY, EXPLORE AND CHARACTERIZE HUMAN BIOLOGICAL SYSTEMS ON THE INDIVIDUAL LEVEL. LARGE QUANTITIES OF BIOMEDICAL DATA ARE NOW BEING GENERATED AND ARCHIVED IN MANY SEPARATE RESEARCH AND CLINICAL ACTIVITIES, BUT THERE EXISTS A PAUCITY OF STUDIES THAT INTEGRATE THE AREAS OF CLINICAL NEUROPSYCHIATRY, PERSONAL GENOMICS AND BRAIN-MACHINE INTERFACES. A SINGLE PERSON WITH SEVERE MENTAL ILLNESS WAS IMPLANTED WITH THE MEDTRONIC RECLAIM_ DEEP BRAIN STIMULATION (DBS) THERAPY DEVICE FOR OBSESSIVE COMPULSIVE DISORDER (OCD), TARGETING HIS NUCLEUS ACCUMBENS/ANTERIOR LIMB OF THE INTERNAL CAPSULE. PROGRAMMING OF THE DEVICE AND PSYCHIATRIC ASSESSMENTS OCCURRED IN AN OUTPATIENT SETTING FOR OVER TWO YEARS. HIS GENOME WAS SEQUENCED AND VARIANTS WERE DETECTED IN THE ILLUMINA WHOLE GENOME SEQUENCING CLINICAL LABORATORY IMPROVEMENT AMENDMENTS (CLIA)-CERTIFIED LABORATORY. WE REPORT HERE THE DETAILED PHENOTYPIC CHARACTERIZATION, CLINICAL-GRADE WHOLE GENOME SEQUENCING (WGS), AND TWO-YEAR OUTCOME OF A MAN WITH SEVERE OCD TREATED WITH DBS. SINCE IMPLANTATION, THIS MAN HAS REPORTED STEADY IMPROVEMENT, HIGHLIGHTED BY A STEADY DECLINE IN HIS YALE-BROWN OBSESSIVE COMPULSIVE SCALE (YBOCS) SCORE FROM_38 TO A SCORE OF_25. A RECHARGEABLE ACTIVA RC NEUROSTIMULATOR BATTERY HAS BEEN OF MAJOR BENEFIT IN TERMS OF FACILITATING A DEGREE OF STABILITY AND CONTROL OVER THE STIMULATION. HIS PSYCHIATRIC SYMPTOMS RELIABLY WORSEN WITHIN HOURS OF THE BATTERY BECOMING DEPLETED, THUS PROVIDING CONFIRMATORY EVIDENCE FOR THE EFFICACY OF DBS FOROCD IN THIS PERSON.WGS REVEALED THAT HE IS A HETEROZYGOTE FOR THE P.VAL66MET VARIANT IN BDNF, ENCODING A MEMBER OF THE NERVE GROWTH FACTOR FAMILY, AND WHICH HAS BEEN FOUND TO PREDISPOSE CARRIERS TO VARIOUS PSYCHIATRIC ILLNESSES. HE CARRIES THE P.GLU429ALA ALLELE IN METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) AND THE P.ASP7ASN ALLELE IN CHAT, ENCODING CHOLINE O-ACETYLTRANSFERASE, WITH BOTH ALLELES HAVING BEEN SHOWN TO CONFER AN ELEVATED SUSCEPTIBILITY TO PSYCHOSES.WE HAVE FOUND THOUSANDS OF OTHER VARIANTS IN HIS GENOME, INCLUDING PHARMACOGENETIC AND COPY NUMBER VARIANTS. THIS INFORMATION HAS BEEN ARCHIVED AND OFFERED TO THIS PERSON ALONG SIDE THE CLINICAL SEQUENCING DATA, SO THAT HE AND OTHERS CAN RE-ANALYZE HIS GENOME FOR YEARS TO COME. TO OUR KNOWLEDGE, THIS IS THE FIRST STUDY IN THE CLINICAL NEUROSCIENCES THAT INTEGRATES DETAILED NEUROPSYCHIATRIC PHENOTYPING, DEEP BRAIN STIMULATION FOR OCD AND CLINICAL-GRADE WGS WITH MANAGEMENT OF GENETIC RESULTS IN THE MEDICAL TREATMENT OF ONE PERSON WITH SEVERE MENTAL ILLNESS. WE OFFER THIS AS AN EXAMPLE OF PRECISION MEDICINE IN NEUROPSYCHIATRY INCLUDING BRAIN-IMPLANTABLE DEVICES AND GENOMICS-GUIDED PREVENTIVE HEALTH CARE. REPORTED EVENT: A 37-YEAR-OLD MAN REPORTEDLY FORGOT TO TAKE THE RECHARGER WITH HIM ON A FOUR-DAY WEEKEND TRIP. ONCE THE BATTERY WAS DEPLETED, ALL OF THE PATIENT¿S SYMPTOMS GRADUALLY RETURNED TO THEIR FULL LEVEL OVER A 24-HOUR PERIOD, INCLUDING SEVERE OBSESSIVE COMPULSIVE DISORDER (OCD), DEPRESSION, AND SUICIDALITY. SINCE THAT EPISODE, THE PATIENT ALWAYS TOOK HIS RECHARGER WITH HIM ON EXTENDED TRIPS. ¿THE ELECTRICAL STIMULATION IS HAVING A DEMONSTRABLE EFFECT ON HIS OCD.¿ FURTHER INFORMATION HAS BEEN REQUESTED; A SUPPLEMENTAL REPORT WILL BE SUBMITTED IF ADDITIONAL INFORMATION IS RECEIVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
643394 ACTIVA STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY MEDTRONIC MED REL MEDTRONIC PUERTO RICO 37612

Patients

Seq Age Sex Outcome Treatment
1 00040 YR Life Threatening